Stammdaten
Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. It offers MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in mice, dogs, and humans. The company was founded in 2020 and is based in Novato, California.
Unternehmen & Branche
| Name | Mosaic ImmunoEngineering Inc. |
|---|---|
| Ticker | CPMV |
| CIK | 0000836564 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 5,4 Mio. USD |
| Beta | -0,77 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -687,846 | -0.10 | 19,882 | -7,476,020 | |
| 2025-09-30 | 10-Q | -165,361 | -0.02 | 55,298 | -7,306,883 | |
| 2025-06-30 | 10-Q | -172,028 | -0.02 | 57,699 | -7,141,522 | |
| 2025-03-31 | 10-Q | -181,320 | -0.03 | 97,784 | -6,969,494 | |
| 2024-12-31 | 10-K | -921,983 | -0.13 | 141,611 | -6,788,174 | |
| 2024-09-30 | 10-Q | -186,730 | -0.03 | 39,950 | -6,635,130 | |
| 2024-06-30 | 10-Q | -293,717 | -0.04 | 12,277 | -6,448,400 | |
| 2024-03-31 | 10-Q | -288,492 | -0.04 | 78,952 | -6,154,683 | |
| 2023-12-31 | 10-K | -1,008,235 | -0.14 | 179,533 | -5,871,058 | |
| 2023-09-30 | 10-Q | -333,246 | -0.05 | 285,528 | -5,581,029 | |
| 2023-06-30 | 10-Q | 19,612 | 0.00 | 369,363 | -5,253,312 | |
| 2023-03-31 | 10-Q | -399,043 | -0.06 | 148,469 | -5,278,393 | |
| 2022-12-31 | 10-K | -2,380,870 | -0.33 | 261,277 | -4,884,758 | |
| 2022-09-30 | 10-Q | -153,652 | -0.02 | 432,927 | -4,357,185 | |
| 2022-06-30 | 10-Q | -929,632 | -0.13 | 223,151 | -4,255,125 | |
| 2022-03-31 | 10-Q | -763,484 | -0.11 | 403,590 | -3,423,490 | |
| 2021-12-31 | 10-K | -3,684,478 | -0.55 | 269,494 | -2,799,011 | |
| 2021-09-30 | 10-Q | -1,047,943 | -0.15 | 445,657 | -2,201,744 | |
| 2021-06-30 | 10-Q | -979,424 | -0.14 | 602,329 | -1,513,786 | |
| 2021-03-31 | 10-Q | -806,843 | -0.15 | 267,530 | -955,141 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.